← Leaderboards
Sissy M Jhiang
Ohio State University
$8,729,538
Attributed
$8,729,538
Total exposure
12
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2005–17$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$9,079,438 · 13
By mechanism
P01$3,222,520 · 2
R01$2,947,359 · 3
P50$1,940,659 · 2
S10$699,800 · 5
R21$269,100 · 1
Top collaborators
No co-investigators on record.
Most similar at Ohio State University
Same institution · by research overlap
- Matthew D Ringel$21,305,885
Others in their field
Top investigators on “Monitor”
- Jeffrey P Krischer · University Of South Florida$631,818,376
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$476,087,269
- Bambra Strokes · Ppd Development Lp$461,655,950
- David Heimbrook · Leidos Biomedical Research, Inc.$367,240,481
- Lawrence Corey · Fred Hutchinson Cancer Center$302,301,802
Research focus
MonitorThyroid GlandMalignant Neoplasm Of ThyroidCellsSymporterMediatingUptakeCancer PatientInhibitor/AntagonistLifeThyroid NeoplasmIodineBiological MarkersEnsureTranslatingTumorUniversitiesPre-ClinicalCancer CenterOhioIodidesSignal TransductionOutcome ForecastTomography, Emission-Computed, Single-Photon
Grant awards (37)
Preserving Salivary Gland Function After Radioiodine Therapy for Thyroid Cancer$312,184
P50 · FY2017 · CA · contact PI
Selective Modulation of Thyroidal Radioiodine$304,611
P01 · FY2017 · CA · contact PI
Developmental Research Program$87,233
P50 · FY2017 · CA · contact PI
Selective Modulation of Thyroidal Radioiodine$338,346
P01 · FY2016 · CA · contact PI
Preserving Salivary Gland Function After Radioiodine Therapy for Thyroid Cancer$315,461
P50 · FY2016 · CA · contact PI
Developmental Research Program$72,738
P50 · FY2016 · CA · contact PI
Selective Modulation of Thyroidal Radioiodine$338,304
P01 · FY2015 · CA · contact PI
Preserving Salivary Gland Function After Radioiodine Therapy for Thyroid Cancer$311,360
P50 · FY2015 · CA · contact PI
Developmental Research Program$74,944
P50 · FY2015 · CA · contact PI
Selective Modulation of Thyroidal Radioiodine$327,279
P01 · FY2014 · CA · contact PI
Preserving Salivary Gland Function After Radioiodine Therapy for Thyroid Cancer$303,201
P50 · FY2014 · CA · contact PI
Developmental Research Program$82,810
P50 · FY2014 · CA · contact PI
Selective Modulation of Thyroidal Radioiodine$338,320
P01 · FY2013 · CA · contact PI
Preserving Salivary Gland Function After Radioiodine Therapy for Thyroid Cancer$292,394
P50 · FY2013 · CA · contact PI
Developmental Research Program$88,334
P50 · FY2013 · CA · contact PI
RET/PTC-mediated Thyroid Tumorigenesis and NIS Modulation$319,272
P01 · FY2012 · CA · contact PI
RET/PTC-mediated Thyroid Tumorigenesis and NIS Modulation$311,150
P01 · FY2011 · CA · contact PI
RET/PTC-mediated Thyroid Tumorigenesis and NIS Modulation$336,592
P01 · FY2010 · CA · contact PI
RET/PTC-mediated Thyroid Tumorigenesis and NIS Modulation$310,919
P01 · FY2009 · CA · contact PI
RET/PTC-mediated Thyroid Tumorigenesis and NIS Modulation$297,727
P01 · FY2008 · CA · contact PI
Sodium lodide Symporter as an Imaging Reporter Gene$314,678
R01 · FY2007 · EB · contact PI
RET/PTC Mediated Thyroid Tumorigenesis and NIS Modulation$285,000
R01 · FY2007 · CA · contact PI
X-SPECTTM for Functional & Anatomic Imaging In Vivo$349,900
S10 · FY2006 · RR · contact PI
Sodium lodide Symporter as an Imaging Reporter Gene$324,077
R01 · FY2006 · EB · contact PI
X-SPECT FOR FUNCTIONAL & ANATOMIC IMAGING IN VIVO:CANCER, LEUKEMIA, LYMPHOMA$216,938
S10 · FY2006 · RR · contact PI
X-SPECT FOR FUNCTIONAL & ANATOMIC IMAGING IN VIVO: BREAST CANCER$69,980
S10 · FY2006 · RR · contact PI
X-SPECT FOR FUNCTIONAL & ANATOMIC IMAGING IN VIVO: PHARMACOLOGY$34,990
S10 · FY2006 · RR · contact PI
X-SPECT FOR FUNCTIONAL & ANATOMIC IMAGING IN VIVO:GENE THERAPY$27,992
S10 · FY2006 · RR · contact PI
Sodium lodide Symporter as an Imaging Reporter Gene$331,875
R01 · FY2005 · EB
NIS Regulation in Breast Cancer$134,550
R21 · FY2005 · CA
Sodium lodide Symporter as an Imaging Reporter Gene$331,875
R01 · FY2004 · EB
NIS Regulation in Breast Cancer$134,550
R21 · FY2004 · CA
Sodium lodide Symporter as an Imaging Reporter Gene$331,875
R01 · FY2003 · EB
THYROID-SPECIFIC RET/PTC ONCOGENE$275,635
R01 · FY2003 · CA
THYROID-SPECIFIC RET/PTC ONCOGENE$268,015
R01 · FY2002 · CA
THYROID-SPECIFIC RET/PTC ONCOGENE$260,619
R01 · FY2001 · CA
THYROID-SPECIFIC RET/PTC ONCOGENE$223,710
R01 · FY2000 · CA